Limiting RyR2 open time prevents Alzheimer's disease‐related deficits in the 3xTG‐AD mouse model
- 5 August 2021
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 99 (11) , 2906-2921
Abstract
Increasing evidence suggests that Alzheimer's disease (AD) progression is driven by a vicious cycle of soluble β‐amyloid (Aβ)‐induced neuronal hyperactivity. Thus, breaking this vicious cycle by suppressing neuronal hyperactivity may represent a logical approach to stopping AD progression. In support of this, we have recently shown that genetically and pharmacologically limiting ryanodine receptor 2 (RyR2) open time prevented neuronal hyperactivity, memory impairment, dendritic spine loss, and neuronal cell death in a rapid, early onset AD mouse model (5xFAD). Here, we assessed the impact of limiting RyR2 open time on AD‐related deficits in a relatively late occurring, slow developing AD mouse model (3xTG‐AD) that bears more resemblance (compared to 5xFAD) to that of human AD. Using behavioral tests, long‐term potentiation recordings, and Golgi and Nissl staining, we found that the RyR2‐E4872Q mutation, which markedly shortens the open duration of the RyR2 channel, prevented learning and memory impairment, defective long‐term potentiation, dendritic spine loss, and neuronal cell death in the 3xTG‐AD mice. Furthermore, pharmacologically shortening the RyR2 open time with R‐carvedilol rescued these AD‐related deficits in 3xTG mice. Therefore, limiting RyR2 open time may offer a promising, neuronal hyperactivity‐targeted anti‐AD strategy.Keywords
Funding Information
- Heart and Stroke Foundation of Canada
- Canadian Institutes of Health Research
This publication has 80 references indexed in Scilit:
- An Update of Animal Models of Alzheimer Disease with a Reevaluation of Plaque DepositionsExperimental Neurobiology, 2013
- Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s DiseasePLOS ONE, 2012
- Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer DiseaseJournal of Neuroscience, 2012
- Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s diseaseProceedings of the National Academy of Sciences of the United States of America, 2012
- Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's diseaseNeurobiology of Aging, 2012
- Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic miceNeuroscience Letters, 2012
- Dantrolene prevents arrhythmogenic Ca2+release in heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ releaseNature Medicine, 2011
- Multiple Events Lead to Dendritic Spine Loss in Triple Transgenic Alzheimer's Disease MicePLOS ONE, 2010
- Role of Presenilins in Neuronal Calcium HomeostasisJournal of Neuroscience, 2010